From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters
作者:Jialin Mao、Hai Yuan、Yuehong Wang、Baojie Wan、Marco Pieroni、Qingqing Huang、Richard B. van Breemen、Alan P. Kozikowski、Scott G. Franzblau
DOI:10.1021/jm900340a
日期:2009.11.26
Both in vitro and in vivo metabolism studies suggested that 5-(2,8-bis(trifluoromethyl)quinolin-4-yloxymethyl)isoxazole-3-carboxylic acid ethyl ester (compound 3) with previously reported anti-tuberculosis activity is rapidly converted to two metabolites 3a and 3b. In order to improve the metabolic stability of this series, chemistry efforts were focused on the modification of the oxymethylene linker of compound 3 in the present study. Compound 9d with an alkene linker was found to be both more metabolically stable and more potent than compound 3, with a minimum inhibitory concentration (MIC) of 0.2 mu M and 2.6 mu M against replicating and nonreplicating Mycobaterium tuberculosis, respectively. These attributes make 9d ail interesting lead compound. A number of modifications were made to the structure of 9d, and it series of active Compounds were discovered. Although some neurotoxicity was observed at it high dosage, this new series was endowed with both improved in vitro anti-TB activity and metabolic stability in comparison to compound 3.
NOC Chemistry for Tuberculosis-Further Investigations on the Structure-Activity Relationships of Antitubercular Isoxazole-3-carboxylic Acid Ester Derivatives
作者:Marco Pieroni、Annamaria Lilienkampf、Yuehong Wang、Baojie Wan、Sanghyun Cho、Scott G. Franzblau、Alan P. Kozikowski
DOI:10.1002/cmdc.201000169
日期:——
NOC, NOC! Who's there? We have expanded the body of structure–activityrelationships (SAR) regarding the 3‐isoxazolecarboxylic acid ethyl esters by the design and synthesis of 5‐aryl‐ and 5‐[(N‐aryl)amino]methyl analogues. Compounds were active against Mycobacterium tuberculosis (Mtb) at sub‐micromolar concentrations and, for selected compounds, no toxicity was observed on Vero cells.